Zelluna (OSE: ZLNA), a company pioneering allogeneic 'off-the-shelf' T Cell Receptor-based Natural Killer (TCR-NK) cell ...

Kinaxis® Inc. ("Kinaxis" or the "Company") (TSX: KXS) today announces that, further to its previously announced intention to ...

A new neuroimaging study suggests that people who frequently control their dreams share distinct structural brain patterns. These networks bridge the areas responsible for self-reflection, visual ...

Oslo, Norway, 09 March 2026 - Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, toda ...

Good morning, everyone, and thank you for participating in today's conference call to discuss Sharplink's financial and operating results for the year ended December 31, 2025. By now, everyone should ...

While that seems predictably unpredictable, 'the political and economic bias of the AI agent's creator may be hard to divine, ...

These three artificial intelligence stocks are better bets than gambling on the prediction markets.

Credo's explosive FY2026 revenue growth, driven by AEC adoption at Microsoft and Google, exceeded expectations. Read why CRDO ...

Amazon has been the worst-performing "Magnificent Seven" stock over the last five years. Don't bet on that happening again.

Quarterhill Inc. ("Quarterhill" or the "Company") (TSX: QTRH) (OTCQX: QTRHF), a leading global provider of intelligent transportation systems ("ITS") solutions, will showcase its integrated commercial ...

Detailed price information for Bioxcel Therapeutics Inc (BTAI-Q) from The Globe and Mail including charting and trades.